The rapidity and severity of the drop is the shorts and MMs. They prey on share price weakness. That weakness comes from Mgmt. Although to be fair though, many Mgmt “mistakes” are through no fault of their own (eg FDA moving goalposts).

Regardless, hopefully we are entering a new chapter when mgmt finally delivers.Start with EUA in Philippines and/or Brazil. Then revenue. Uplist. EUAs worldwide. Cancer BTD. More trials. More revenue. Full approvals. Crazy revenue. BIG pps.